CA2149317A1 - Compositions and method for providing improved analgesic effect - Google Patents

Compositions and method for providing improved analgesic effect

Info

Publication number
CA2149317A1
CA2149317A1 CA002149317A CA2149317A CA2149317A1 CA 2149317 A1 CA2149317 A1 CA 2149317A1 CA 002149317 A CA002149317 A CA 002149317A CA 2149317 A CA2149317 A CA 2149317A CA 2149317 A1 CA2149317 A1 CA 2149317A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
ibuprofen
composition according
onset
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002149317A
Other languages
English (en)
French (fr)
Inventor
Richard Wilfred D'souza
Sekhar Mitra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2149317A1 publication Critical patent/CA2149317A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002149317A 1992-12-21 1993-12-10 Compositions and method for providing improved analgesic effect Abandoned CA2149317A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99437192A 1992-12-21 1992-12-21
US07/994,371 1992-12-21

Publications (1)

Publication Number Publication Date
CA2149317A1 true CA2149317A1 (en) 1994-07-07

Family

ID=25540587

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002149317A Abandoned CA2149317A1 (en) 1992-12-21 1993-12-10 Compositions and method for providing improved analgesic effect

Country Status (9)

Country Link
EP (1) EP0674517A1 (ja)
JP (1) JPH08504818A (ja)
CN (1) CN1094615A (ja)
AU (1) AU672279B2 (ja)
BR (1) BR9307697A (ja)
CA (1) CA2149317A1 (ja)
MX (1) MX9400038A (ja)
PE (1) PE56194A1 (ja)
WO (1) WO1994014449A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7604194A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
CA2227958A1 (en) * 1995-07-28 1997-02-13 Sekhar Mitra Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
JPH0987174A (ja) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd 鎮痛性および抗炎症性組成物
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US7863287B2 (en) * 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
PL2012763T3 (pl) * 2006-04-28 2011-08-31 Gruenenthal Gmbh Kombinacja farmaceutyczna zawierająca 3-(3-dimetyloamino-1-etylo-2-metylo-propylo)-fenol i NSAID

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
WO1991006295A1 (en) * 1989-11-06 1991-05-16 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
AU8764191A (en) * 1990-09-28 1992-04-28 Mcneill-Ppc Inc. Ibuprofen-antihistamine combinations

Also Published As

Publication number Publication date
EP0674517A1 (en) 1995-10-04
CN1094615A (zh) 1994-11-09
AU672279B2 (en) 1996-09-26
BR9307697A (pt) 1999-05-25
PE56194A1 (es) 1995-01-26
JPH08504818A (ja) 1996-05-28
AU5899394A (en) 1994-07-19
WO1994014449A1 (en) 1994-07-07
MX9400038A (es) 1994-07-29

Similar Documents

Publication Publication Date Title
EP0180597B1 (en) Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
CA2237306C (en) Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
JP3924321B2 (ja) 疼痛軽減医薬組成物及び疼痛軽減方法
AU7604094A (en) Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
AU4930793A (en) Pharmaceutical compositions and methods for treating cold symptoms
CA2170485C (en) Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
SE466481B (sv) Analgetiska och anti-inflammatoriska kompositioner innefattande koffein
CA2149317A1 (en) Compositions and method for providing improved analgesic effect
WO1994014476A1 (en) Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
EP0841947A1 (en) Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
FR2556216A1 (fr) Nouveau medicament analgesique contenant du proglumide, eventuellement en association avec des medicaments analgesiques-narcotiques
US4687781A (en) Analgesic and anti-inflammatory compositions
AU663857B2 (en) Dextromethorphan antitussive compositions
CA2090234C (en) Method for providing improved analgesic effect
WO1992004022A1 (en) Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
EP0529898A1 (en) Potentiation of the antitussive effect of dextromethorphan with acetaminophen (paracetamol)
Flores-Murrieta et al. Pharmacologic properties of ketorolac tromethamine: a potent analgesic drug
EP0004040B1 (en) Pharmaceutical compositions having analgesic properties comprising a compound selected from d- and dl-phenylalanine, d- and dl-leucine and hydrocinnamic acid in the unit dose of at least 200mg
US4579843A (en) Analgesic and anti-inflammatory compositions
JPH0959149A (ja) 消炎鎮痛組成物
WO1997048390A1 (en) Analgesics combining acetaminophen with meclizine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead